Jul 6, 2022

Beyond a CRISPR treatment’s encouraging results, some scientists see a need for more data on risk

Posted by in categories: biotech/medical, genetics

What happens when you CRISPR people?

Few questions generated more contentious discussion in biotech in the mid-2010s, as researchers and executives debated the relative merits of preclinical studies that pointed both to the new gene-editing tool’s potential to cure numerous diseases and its potential to cause unintended genetic damage.

Leave a reply